About


Center Overview

The Altoona Center for Clinical Research was founded in 1991 by Alan J. Kivitz, MD, CPI. This is a privately owned, 40,000 square foot state-of-the-art research and group private practice facility that includes four Rheumatologists. The center also has a five (5) bed overnight or extended stay facility for conducting Phase I and Pharmacokinetic and Pharmacodynamic studies. ACCR is dedicated to providing quality clinical research with the highest standards of patient safety. Over 740 studies have been completed at the center for at least 100 different Sponsors and CRO’s. ACCR has met or exceeded promised enrollment goals in the vast majority of these trials. A separate employee is dedicated solely to patient recruitment.

Services Provided

ACCR conducts Phase 1 through IV clinical trials. We are highly experienced in, but not limited to, the following indications:

  • Ankylosing Spondylitis
  • BPH
  • Chronic Pain
  • Device Trials
  • Diabetic Neuropathy
  • Fibromyalgia
  • GERD
  • Gout
  • Hyperlipidemia or Cholesterol Disorders
  • Insomnia
  • Low Back Pain
  • Lupus
  • Obesity
  • Osteoarthritis
  • Osteoporosis
  • Overactive Bladder
  • Psoriasis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Stress Urinary Incontinence
  • User Accessability Testing - Trials

 

Patient Demographics

As the sole group Rheumatology practice in Blair County, The Altoona Center for Clinical Research draws its patients from a nine county area, approximately 750,000 people.  ACCR has more than 65,000 patients in their electronic database, and typically fulfills 85% of the enrolled subjects in most clinical trials, from these files.
 
 

Pharmaceutical Partners

Adolor
AEGERA
Alcon
Alexion
Allergan
Alpharma
Alza
Angiotech
ARRAY
Astellas
AstraZeneca
Aventis
Berlex
Biogen
Bio-Technology
Boehringer Ingelheim
Bristol-Myers Squibb
Celltech
Centocor
Chiesi
Corixa/Anergen
CORRONA
Cypress Bioscience
Dimethaid
Eisai
Eli Lilly
Enzymerx

FLEXX
Forest
Fresenius Hemocare
Genentech
Genmab
GILEAD
Glaxo-Wellcome
Grunenthal
Hisamitsu
Human Genome Sciences
IDEA
Immune
Immunex
Incyte
Inflammatics
Johnson & Johnson
Knoll
MacroChem
MedImmune
Merckle
Merrimack
Millennium
NARAC
Neurocrine
Neurogen
NeurogesX
Neuromed

NicOx
Noven
Orphan
Ortho
Orthobiotech
Ortho-McNeil
Parke-Davis
Pfizer
Phytomedics
Pozen
Primus
Proctor & Gamble
Regeneron
Reliant
Rigel
Rinat
Roche
Roxanne
RW
Sanofi
Savient
Schering-Plough
Schwarz
Scios
Seikagaku
Sepracor
Seracare

 

Serono
Shire
SmithKline
Sucampo
Targeted Genetics
TorreyPines
Trubuon
UCB
Unigene/Tarsa
United Therapeutics
University of Alabama at Birmingham
University of Massachussetts
University of PA
Veldona
Vertex
XOMA
Yamanouchi
Zars
Zeneca